These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9192336)

  • 1. Cardioversion of atrial arrhythmias: audit of anticoagulation management.
    Mayet J; Wasan B; Sutton GC
    J R Coll Physicians Lond; 1997; 31(3):313-6. PubMed ID: 9192336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: a single centre 8.5-year experience.
    Corrado G; Santarone M; Beretta S; Tadeo G; Tagliagambe LM; Foglia-Manzillo G; Spata M; Miglierina E; Acquati F; Santarone M
    Europace; 2000 Apr; 2(2):119-26. PubMed ID: 11225938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
    Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
    G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
    Manning WJ; Silverman DI; Keighley CS; Oettgen P; Douglas PS
    J Am Coll Cardiol; 1995 May; 25(6):1354-61. PubMed ID: 7722133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation.
    Schlicht JR; Davis RC; Naqi K; Cooper W; Rao BV
    Arch Intern Med; 1996 Feb; 156(3):290-4. PubMed ID: 8572839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.
    Wu LA; Chandrasekaran K; Friedman PA; Ammash NM; Ramakrishna G; Hart CY; Moon BS; Herges RM; Rosales AG; Malouf JF
    Am J Med; 2006 Feb; 119(2):142-6. PubMed ID: 16443416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future].
    Schimpf T; Stellbrink C
    Med Klin (Munich); 2003 Feb; 98(2):91-5. PubMed ID: 12601533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi.
    Manning WJ; Silverman DI; Gordon SP; Krumholz HM; Douglas PS
    N Engl J Med; 1993 Mar; 328(11):750-5. PubMed ID: 8437595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for cardioversion of atrial arrhythmias.
    Mayet J; More RS; Sutton GC
    Eur Heart J; 1998 Apr; 19(4):548-52. PubMed ID: 9597402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography.
    Mehta D; Baruch L
    Chest; 1996 Oct; 110(4):1001-3. PubMed ID: 8874259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism.
    Bertaglia E; D'Este D; Franceschi M; Pascotto P
    Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthoracic echocardiography for precardioversion screening during atrial flutter/fibrillation in young patients.
    Horenstein MS; Karpawich PP; Epstein ML; Singh TP
    Clin Cardiol; 2004 Jul; 27(7):413-6. PubMed ID: 15298044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
    Femia G; Fetahovic T; Shetty P; Lee A
    Heart Lung Circ; 2018 Jul; 27(7):798-803. PubMed ID: 28802808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
    Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
    J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
    Klein HH
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances.
    Kerber RE
    Am J Cardiol; 1996 Oct; 78(8A):22-6. PubMed ID: 8903272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated.
    Densèm CG
    Am J Cardiol; 1999 Jan; 83(1):140-1. PubMed ID: 10073808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.